GlassScriptPhysician profile
Harley Randall Hendrix
NPI 1003265836
$715.01
in general payments reported to CMS, 2019-2025
18 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.59 · 2020: $47.56 · 2021: $70.51 · 2022: $89.33 · 2023: $230 · 2024: $107 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $147.98 | 2023 | Carto 3 |
| Novo Nordisk INC | $105.48 | 2021-2025 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $77.90 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $51.34 | 2024-2025 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $43.67 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.98 | 2022-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $37.58 | 2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $26.98 | 2024 | |
| Pbg Puerto Rico LLC | $26.00 | 2021 | |
| Pfizer INC. | $24.44 | 2025 | |
| Jazz Pharmaceuticals INC. | $20.73 | 2020 | |
| Idorsia Pharmaceuticals US INC | $20.26 | 2023 | Quviviq |
| Lilly USA, LLC | $19.45 | 2025 | Mounjaro |
| Amgen INC. | $17.75 | 2023 | Repatha |
| Abbvie INC. | $15.80 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $14.90 | 2024 | Voquezna |
| Medtronic, INC. | $13.79 | 2023 | Venaseal |
| Exact Sciences Corporation | $12.98 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harley Hendrix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.